Analyst Ratings for Horizon Pharma PLC (HZNP)Updated: 2017-07-26
Analysts covering Horizon Pharma PLC (NASDAQ:HZNP) have given it a consensus rating of Buy. About 30 days ago, HZNP was issued an average rating of Buy.
11 analysts issued ratings on the stock, where 9 gave HZNP a buy rating, 0 issued an overweight rating, 2 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Today, there are 0 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
Investment analysts gave a few price targets for HZNP. The maximum price target given was 22, implying potential capital gains of 66.41 percent. The lowest price target was 10, implying potential capital losses of -24.36 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. That number becomes -76.76 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. If we look at the last 90 days instead, we find a net average change of -66.14 percent in FY estimates.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts made negative revisions to their fiscal year's estimates.
In the last 52-weeks, HZNP has achieved a high of 23.44 and a low of 9.45. The current market price is above the trailing year's low by 39.89 percent, and below the high by 43.6 percent. HZNP has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The HZNP value stock report compares HZNP to some of its peers using value stock charts. The stock has a market capitalization of $2.19 billion. HZNP is estimated to release their earnings results for the quarter on 0000-00-00, days from today.